COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 15:15

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company focused on developing and commercializing [...]

NSS Labs Selected as a 2017 Red Herring Top 100 Global Winner

21/11/2017 - 15:00

AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance today announced that it has been selected as a winner of the Red [...]

Zynerba Pharmaceuticals Announces Poster Presentation at the 2017 Annual Meeting of the American Epilepsy Society (AES)

21/11/2017 - 15:00

DEVON, Pa., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ: ZYNE ), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically- [...]

Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)

21/11/2017 - 15:00

NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced clinical trial results from its first phase II [...]

Nextech Reports Key Wins, Corporate Expansions

21/11/2017 - 14:50

TAMPA, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, is pleased to announce a wide variety of corporate wins and [...]

CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017

21/11/2017 - 14:45

LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017 Company enters its 3rd year exhibiting its industry-dominating brand, [...]

AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases

21/11/2017 - 14:32

Lausanne, Switzerland, November 21, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will [...]

Marrone Bio Innovations, Inc. to Present at 10th Annual LD Micro Main Event Investor Conference in Los Angeles

21/11/2017 - 14:30

DAVIS, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]

Dova Pharmaceuticals to Present at Evercore ISI Conference

21/11/2017 - 14:30

DURHAM, N.C., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Evercore ISI [...]

Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2017 Results

21/11/2017 - 14:30

TORONTO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it [...]

Novelion Therapeutics Provides Update on Agreement between Aegerion Pharmaceuticals and U.S. Department of Justice

21/11/2017 - 14:30

VANCOUVER, British Columbia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%

21/11/2017 - 14:30

BUENA, N.J., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017 at 7:30 a.m.

21/11/2017 - 14:30

Will present data from its NO-NTM Phase 2 clinical trial for patients suffering from Nontuberculous Mycobacteria (NTM) Abscessus NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical- [...]

Catalyst Pharmaceuticals Announces Phase 2 Study of Firdapse® in Ambulatory Patients with Spinal Muscular Atrophy (SMA)

21/11/2017 - 14:03

CORAL GABLES, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]

Auris Medical News Release

21/11/2017 - 14:01

Auris Medical to Report Third Quarter 2017 Financial Results and Provide Business Update on Tuesday, November 28, 2017 Zug, Switzerland, November 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage [...]

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

21/11/2017 - 14:00

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]

Altimmune to Present at the 29th Annual Piper Jaffray Conference

21/11/2017 - 14:00

GAITHERSBURG, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today announced that Bill Enright, president and chief executive officer of Altimmune, [...]

Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]

Menlo Therapeutics Begins Phase 2 Clinical Trial for Pruritus Associated with Psoriasis

21/11/2017 - 14:00

REDWOOD CITY, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc., a late-stage biopharmaceutical company developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus ( [...]